Background and Objectives
Mycoplasma pneumoniae has been implicated with community-acquired pneumonia and mild to severe respiratory infections in the normal population. The prevalence of this mollicute in HIV infected patients has never been reported from India. Mycoplasmas have also been reported to act as cofactors in AIDS progression. 
Aims and Objectives

Materials and methods
The present study has been carried out on 60 HIV infected patients presenting with underlying pulmonary complaints and whose clinical presentation was consistent with disease caused by Mycoplasma pneumoniae, after obtaining informed consent subsequent to approval by the Institutional Review Board (IRB) on human ethics in Chennai where the recovery rates of Mycoplasma pneumoniae from induced sputum and throat swab specimens of HIV infected patients were compared and the haematological and immunological findings were analysed. Patients screened were from the age groups ranging from 15 to 60 years, whose respiratory specimens were cultured on PPLO glucose agar and broth, the later with 1% methylene blue. Presumptive identification of Mycoplasma pneumoniae was carried out using guidelines proposed by the Subcommittee on the Taxonomy of Mollicutes, 1979 . The respiratory specimens from the HIV-infected subjects were later analysed for their recovery rates, incidence of other bacterial, fungal pathogens, AFB, Pneumocystis carinii and their correlation features with CD4+ and CD8+ lymphocytes were also analysed and compared.
Results and Conclusion
The male to female ratio of the study population was 51:09. The mean age of the patients was 39 years. M. pneumoniae was presumptively detected from 23 (38.3%) of the HIV infected patients. Induced sputum and throat swabs yielded 82.6% and 55% of the mycoplasma isolates respectively, which suggests that induced sputum can be the better specimen compared to throat swabs. Simultaneous positivity of both specimens was detected in 13 (56.5%) cases. <supplement> <title> <p>2005 International Meeting of The Institute of Human Virology</p> </title> <note>Meeting abstracts -A single PDF containing all abstracts in this Supplement is available here. [link 'here' using 'a href' to: <url>http://www.biomedcentral.com/content/pdf/1742-4690-2-S1-full.pdf</url>]</note> </supplement>
